EGE UNIVERSITY

Research and Application Center of Drug Development and Pharmocokinetics

Phase Research

Phase I studies: Generally, in healthy volunteers, 20-80 people are collecting safety data related to the product, determining the dose range, examining the tolerable dose and pharmacokinetic properties. The main purpose of this phase is 'safety'. Phase I studies can also be performed on patient volunteers in some cases.